First sleep apnea oral therapy available for co-development. Phase II study completed with positive results. Company has completed first round of financing raising $40 million. Market is highly unsatisfied. Strong IP protection through 2039.
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/Phase-3-icon.png 300 300 Jim Usry https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png Jim Usry2020-11-06 18:59:592021-10-31 18:07:23Company with sleep apnea asset seeks development partner